Request Deal Involvement
Fosun Pharma terminated the acquisition of the remaining 40.44% stake in Henlius for HKD5.4bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Freshfields Bruckhaus Deringer
financial advisors
Bank of China
financial advisors
Rainbow Capital
financial advisors
China International Capital
financial advisors
Fosun Capital
or
Principals
target
HENLIUS
bidder
SHANGHAI FOSUN PHARMACEUTICAL
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite